See What HealthDay Can Do For You
Contact Us

Early Neurologic Symptoms Can Forecast Tardive Dyskinesia

About half of schizophrenics with tardive dyskinesia showed extrapyramidal symptoms

WEDNESDAY, Aug. 30 (HealthDay News) -- Extrapyramidal symptoms induced by antipsychotic drugs could forecast tardive dyskinesia in about 50 percent of schizophrenics, researchers report in the August issue of the American Journal of Psychiatry.

Jim van Os, M.D., Ph.D., of Maastricht University in the Netherlands, and colleagues assessed neurologic symptoms and tardive dyskinesia in 9,298 patients in a European study.

The researchers found that patients with extrapyramidal symptoms at baseline were more likely to develop tardive dyskinesia than those who did not have symptoms at baseline (hazard ratio, 2.0). About 50 percent of those who developed tardive dyskinesia exhibited extrapyramidal symptoms beforehand.

"Although the association of tardive dyskinesia and extrapyramidal symptoms is significant, extrapyramidal symptoms do not robustly identify individuals at high risk for tardive dyskinesia," the authors write. "However, drug regimens and disease processes that increase extrapyramidal symptoms are likely to result in increased risk of tardive dyskinesia."

In an accompanying editorial, John M. Kane, M.D., of Hillside Hospital in Glen Oaks, N.Y., writes that while newer medications entail lower risk, "there remain unanswered questions about the differences in relative risk, the role of dose, and comparisons with a variety of different conventional agents."

Abstract
Full Text (subscription or payment may be required)
Editorial

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.